Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giona Castagna

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Diabetologica|November 22, 2024
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systemsNicolò Diego Borella, Antonio Ferramosca, Giona Castagna, et al.
Pituitary|May 6, 2025
Kidney function in acromegaly: evidence from a long-term observational studyGiona Castagna, Silvia Ippolito, Sara Cassibba, et al.
Diabetes Technology & Therapeutics|October 30, 2023
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best EfficacyGiuseppe Lepore, Nicolò Diego Borella, Giona Castagna, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 1, 2024
Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational ProgramLaura Molteni, Giuseppe Marelli, Giona Castagna, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Diabetologica|November 22, 2024
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systemsNicolò Diego Borella, Antonio Ferramosca, Giona Castagna, et al.
Pituitary|May 6, 2025
Kidney function in acromegaly: evidence from a long-term observational studyGiona Castagna, Silvia Ippolito, Sara Cassibba, et al.
Diabetes Technology & Therapeutics|October 30, 2023
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best EfficacyGiuseppe Lepore, Nicolò Diego Borella, Giona Castagna, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 1, 2024
Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational ProgramLaura Molteni, Giuseppe Marelli, Giona Castagna, et al.
Pageof 1